*Some Market data delayed by 15 mins.

Theriva Biologics, Inc.

Symbol: TOVX (NYSE)
0.25 ▼ (-4.67%) -0.012

Company Description:
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Key Stats
  • Today's Open: $0.2596
  • Today's High: $0.276
  • Today's Low: $0.242
  • Today's Volume: 63.54K
  • Yesterday Close: $0.257
  • Yesterday High: $0.2597
  • Yesterday Low: $0.2422
  • Yesterday Volume: 225.17K
  • Last Min Volume: 50
  • Last Min High: $0.245
  • Last Min Low: $0.245
  • Last Min VWAP: $0.245
Company Profile
  • Name: Theriva Biologics, Inc.
  • Website: https://www.therivabio.com
  • Listed Date: 1993-04-05
  • Location: ROCKVILLE, MD
  • Market Status: Active
  • CIK Number: 0000894158
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $4.28M
  • Round Lot: 100
  • Outstanding Shares: 17.28M
  • Asset Type: CS
RECENT FILINGS FOR TOVX
Filing DateFiling TypeFormat
2024-05-238-KView
2024-05-168-KView
2024-05-0710-QView
2024-05-078-KView
2024-05-02S-3View
2024-05-028-KView
2024-04-238-KView
2024-04-228-KView
2024-04-168-KView
2024-03-2510-KView
2024-03-258-KView
2024-02-078-KView
2024-01-088-KView
2023-12-154View
2023-12-154View
2023-12-154View
2023-12-154View
2023-11-1310-QView
2023-11-138-KView
2023-10-238-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.